Speaker illustration

Mr Viet Ngoc Nguyen

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology

Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Heart failure pharmacology

Thumbnail

This platform is supported by

logo Novo Nordisk